Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesDrinking coffee slows progression of liver disease in chronic hepatitis C sufferers
EurekAlert, 10/21/09
Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non–coffee drinkers according to a new study led by Neal Freedman, Ph.D., MPH, from the National Cancer Institute (NCI). The study found that patients with hepatitis C–related bridging fibrosis or cirrhosis who did not respond to standard disease treatment benefited from increased coffee intake. An effect on liver disease was not observed in patients who drank black or green tea. Findings of the study appear in the November issue of Hepatology, a journal published by Wiley–Blackwell on behalf of the American Association for the Study of Liver Diseases.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Negative emotions outweigh intent to exercise at health clubs
ScienceDaily, 12/18/09
Breakthrough May Pave the Way for Therapeutic Vaccines
ScienceDaily, 12/18/09
Should flowers be banned in hospitals?
ScienceDaily, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor